Frattola L, Albizzati M G, Alemani A, Bassi S, Ferrarese C, Trabucchi M
J Neurol Sci. 1983 May;59(2):247-53. doi: 10.1016/0022-510x(83)90042-4.
The authors studied the effects of lisuride hydrogen maleate (lisuride) on the hyperkinesias of 11 patients suffering from Huntington's chorea (HC). In all patients, acute injection of 150 micrograms of the drug induced a marked temporary improvement of the abnormal involuntary movements; the favourable drug-effect was more pronounced in the patients with a less severe degree of hyperkinesia. The antichoreic activity of the drug was prevented by pretreatment with haloperidol (2 mg) or sulpiride (400 mg), both injected intramuscularly 30 min before lisuride administration. The authors suggest the improvement of the motor disturbance induced in HC by lisuride may be explained on the basis of its preferential action on a subset of brain dopaminergic receptor.
作者研究了马来酸氢麦角乙脲(麦角乙脲)对11例亨廷顿舞蹈病(HC)患者运动亢进的影响。对所有患者而言,急性注射150微克该药物可使异常不自主运动得到显著的暂时改善;在运动亢进程度较轻的患者中,药物的有利效果更为明显。在注射麦角乙脲前30分钟肌肉注射氟哌啶醇(2毫克)或舒必利(400毫克)进行预处理,可阻止该药物的抗舞蹈病活性。作者认为,麦角乙脲对HC所致运动障碍的改善作用,可能是基于其对脑内一部分多巴胺能受体的优先作用来解释的。